Mohammed Suhail Chaudhry, MD, PhD
Executive Medical Director, Early Clinical Development Oncology @ Cullinan Therapeutics
About
I am a drug developer with expertise in immunotherapy, dedicated to improving outcomes of patients with cancer. In my role as an Executive Medical Director in Early Clinical Development at Cullinan Therapeutics I have assumed the dual responsibilities of Program Team Lead and Clinical Lead. It is a joy to move forward with a team of highly motivated colleagues and combine my passion for both clinical medicine and basic science. I studied clinical medicine at the University of Cambridge and undertook fellowship in Hematology/Oncology in London. My clinical expertise is complemented by extensive laboratory research experience founded upon a PhD program in tumor immunology at Imperial College London and subsequent research fellowships in cancer immunotherapy at Memorial Sloan Kettering Cancer Center and Icahn School of Medicine at Mount Sinai. I am the lead-author/co-author of numerous high impact original research papers, clinical reports and review articles. I am determined to pioneer Diversity and Inclusion within our industry, and I am the lead-author of a 2022 highly cited Nature Medicine article highlighting the need for Inclusive Research in biotech (https://rdcu.be/cO4qR).
United States
San Francisco Bay Area
Research
Immunotherapy, Laboratory Research, Clinical Medicine, Cell culture including complex 3D models, Multi-parameter flow cytometry, 2D microscopy, Optical clearing and 3D imaging of tissues, Nucleic acid extraction, Chromatin immunoprecipitation, Single cell RNA-sequencing, Transfection and lentiviral transduction
Experience
Executive Medical Director, Early Clinical Development Oncology
Cullinan Therapeutics
Cambridge, Massachusetts, United States
◾ Program Team Lead and Clinical Science Team Lead for the development of a novel immunotherapy asset in acute myeloid leukemia ➤ Defines and delivers the integrated program strategy through coordination of all key functions, and ensures its validation by key stakeholders ➤ Drives the clinical development strategy and provides medical monitor oversight for clinical trials ◾ Clinical Science Team Lead for the development of novel immunotherapies in multiple myeloma and solid tumors
Senior Medical Director, Early Clinical Development Oncology
Cullinan Therapeutics
Cambridge, Massachusetts, United States
Lead Medical Director, Early Clinical Development Oncology
Genentech
South San Francisco, California, United States
◾ Clinical Science Team Lead for the development of novel cancer immunotherapies and targeted therapies in solid tumors ◾ Co-lead for Diversity, Equity and Inclusion strategy within Early Clinical Development
Medical Director, Early Clinical Development Oncology
Genentech
South San Francisco, California, United States
Post-Doctoral Research Fellow, Ferrara Lab
Icahn School of Medicine at Mount Sinai
Greater New York City Area
◾ Immunobiology of T cell therapies using 3D cell culture and murine models ◾ Mechanisms of immune-mediated intestinal crypt damage and regeneration ◾ Lentiviral engineered endothelial cells as a cellular therapy for intestinal regeneration ◾ Serum biomarkers to predict acute graft-versus-host disease in patients
Visiting Research Fellow, van den Brink Lab
Memorial Sloan Kettering Cancer Center
Greater New York City Area
◾ T cell immune reconstitution after stem cell transplantation ◾ Mechanisms of thymic damage and regeneration
Fellow in Hematology/Oncology
Health Education England
London, United Kingdom
◾ Malignant hematology and adult stem cell transplantation, Royal Free Hospital ◾ Malignant hematology and adult stem cell transplantation, Hammersmith Hospital ◾ Non-malignant hematology and pediatric stem cell transplantation, St Mary’s Hospital ◾ Malignant and non-malignant hematology, Northwick Park Hospital
Resident in Internal Medicine
Health Education England
Manchester, United Kingdom
◾ General internal medicine, Fairfield General Hospital ◾ Neurology, Salford Royal Hospital
Senior Resident in Hematology/Oncology
Health Education England
Cambridge, United Kingdom
◾ Malignant hematology and adult stem cell transplantation, Addenbrooke's Hospital
Resident in Internal Medicine
Health Education England
Manchester, United Kingdom
◾ Pulmonology, Manchester Royal Infirmary ◾ Hematology, Manchester Royal Infirmary ◾ Geriatric medicine, Manchester Royal Infirmary ◾ Critical care medicine, Manchester Royal Infirmary ◾ Emergency medicine, Manchester Royal Infirmary
Intern in Internal Medicine/General Surgery
Health Education England
Cambridge, United Kingdom
◾ General surgery, Hinchingbrooke Hospital ◾ Gastroenterology, Hinchingbrooke Hospital ◾ Geriatric medicine, Addenbrooke’s Hospital
Wellcome Trust Clinical Research Fellow, Karadimitris Lab
Imperial College London
London, United Kingdom
◾ Regulation of the CD1d-iNKT cell axis in B cells ◾ Mechanisms of immune evasion in B cell malignancies
NIHR Academic Clinical Fellow, Karadimitris Lab
Imperial College London
London, United Kingdom
◾ Training in basic research methods
Education
University of Cambridge
Natural Sciences-Pharmacology and Pre-Clinical Studies
University of Cambridge
Imperial College London
Tumor Immunology
Mohammed Suhail Chaudhry, MD, PhD's Contact Information
Phone
Find the Right Leads
Find Verified Contact Data
What LeadContact does well
Find verified emails, phone numbers, and decision-makers with 98% accuracy.
Find Leads
Find the right people by company, role, industry, location, and more.
925M+ professional profiles
Find Emails
Access verified email addresses for your target contacts.
657M+ emails
Find Phone Numbers
Get cross-validated phone data from multiple top sources.
239M+ phone numbers
More Accurate. Lower Cost.
Find contact data in 1 tool with 98% accuracy
LeadContact integrates leading enrichment tools to deliver more accurate contact data—without paying for each one.
Great conversations start with the right contact.
It’s time to find yours.